Sumonerimod CAS 2433782-42-2 MFC25H26F3NO3 MW445.5 3-(5-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-3-methyl-1H-indol-2-yl)propanoic acid, 1H-Indole-2-propanoic acid, 5-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-3-methyl- 5-[[4-Cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-3-methyl-1H-indole-2-propanoic acid 3-[5-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-3-methyl-1H-indol-2-yl]propanoic acid 3-(5-{[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy}-3-methyl-1Hindol-2-yl)propanoic acidsphingosine-1-phosphate receptor 1 agonist, immunomodulator, S1P1 agonist 6, 49KZ2L5DUV, CBP-307,…
Sosimerasib Cas 2839563-01-6 MF C36H39ClFN7O4 MW688.2 g/mol (2R,4aR,8M)-11-chloro-6-[2-(dimethylamino)ethyl]-10-(2-fluoro-6-hydroxyphenyl)-2-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-3-(prop-2-enoyl)-2,3,4,4a,6,8-hexahydro-1Hpyrazino[1′,2′:4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione (4R,7R)-16-chloro-9-[2-(dimethylamino)ethyl]-15-(2-fluoro-6-hydroxyphenyl)-4-methyl-12-(4-methyl-2-propan-2-yl-3-pyridinyl)-5-prop-2-enoyl-2,5,9,12,14-pentazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),13,15,17-tetraene-8,11-dione 1H-Pyrazino[1′,2′:4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione, 11-chloro-6-[2-(dimethylamino)ethyl]-10-(2-fluoro-6-hydroxyphenyl)-2,3,4,4a,6,8-hexahydro-2-methyl-8-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-3-(1-oxo-2-propen-1-yl)-, (2R,4aR,8R)- (4R,7R)-16-chloro-9-[2-(dimethylamino)ethyl]-15-(2-fluoro-6-hydroxyphenyl)-4-methyl-12-(4-methyl-2-propan-2-yl-3-pyridinyl)-5-prop-2-enoyl-2,5,9,12,14-pentazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),13,15,17-tetraene-8,11-dione (2R,4aR,8M)-11-chloro-6-[2-(dimethylamino)ethyl]-10-(2-fluoro-6-hydroxyphenyl)-2-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-3-(prop-2-enoyl)-2,3,4,4a,6,8-hexahydro-1Hpyrazino[1′,2′:4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dioneKirsten rat sarcoma viral oncogene homolog inhibitor, antineoplastic, HBI-2438, JMKX1899, HBI 2438,…
Tiratricol CAS 51-24-1, 1477-04-9 (hydrochloride salt) MFC14H9I3O4 MW621.93 g/mol 9/28/2026, Emcitate, FDA 2026, APPROVALS 2026, Triac 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid 3,3′,5-TRIIODOTHYROACETIC ACID Triiodothyroacetic acid To treat peripheral…
Zilurgisertib CAS 2173389-57-4 MW 502.6 g/mol MFC30H38N4O3 Atebrioz, FDA 2026, APPROVALS 2026, L5Z9S25HO2, INCB 000928 2-amino-N-(4-hydroxy-1-bicyclo[2.2.2]octanyl)-5-[4-[(1R,5S)-3-(oxan-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]phenyl]pyridine-3-carboxamide To reduce the volume of total new heterotopic ossification…
Reblogged this on MariaGairos–DRUGS.
LikeLike
Reblogged this on MEDCHEMEGYPT.
LikeLike
Reblogged this on MedChemHot.Pakistan.
LikeLike
Reblogged this on Med.Chem.in.Iceland.
LikeLike
Hi there, I enjoy reading through your article. I like to
write a little comment to support you.
LikeLike
Hi there very nice web site!! Man .. Beautiful .. Wonderful ..
I’ll bookmark your website and take the feeds also?
I am satisfied to search out a lot of helpful information here in the publish, we want develop extra strategies in this regard, thank you for sharing.
. . . . .
LikeLike